These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6435386)

  • 1. Weight gain during treatment with valproate.
    Dinesen H; Gram L; Andersen T; Dam M
    Acta Neurol Scand; 1984 Aug; 70(2):65-9. PubMed ID: 6435386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproic acid, curly hair and weight gain].
    Bittencourt PR
    Arq Neuropsiquiatr; 1986 Mar; 44(1):78-81. PubMed ID: 3090984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
    Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
    Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of excessive weight gain in epileptic children treated with valproate.
    Novak GP; Maytal J; Alshansky A; Eviatar L; Sy-Kho R; Siddique Q
    J Child Neurol; 1999 Aug; 14(8):490-5. PubMed ID: 10456757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium valproate in 100 children with special reference to weight.
    Egger J; Brett EM
    Br Med J (Clin Res Ed); 1981 Aug; 283(6291):577-81. PubMed ID: 6790086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
    Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
    Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract]   [Full Text] [Related]  

  • 10. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
    Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
    J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which drug for the adult epileptic patient: phenytoin or valproate?
    Turnbull DM; Howel D; Rawlins MD; Chadwick DW
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):815-9. PubMed ID: 3919805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.
    Verrotti A; D'Egidio C; Mohn A; Coppola G; Chiarelli F
    Obes Rev; 2011 May; 12(5):e32-43. PubMed ID: 20880119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid.
    Greco R; Latini G; Chiarelli F; Iannetti P; Verrotti A
    Neurology; 2005 Dec; 65(11):1808-9. PubMed ID: 16344528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S; Mostardini R; Piccini B; Balestri P
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of sodium valproate in childhood epilepsy.
    McQueen JK; Blackwood DH; Minns RA; Brown JK
    Scott Med J; 1982 Oct; 27(4):312-7. PubMed ID: 6815799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate.
    Aydin K; Serdaroglu A; Okuyaz C; Bideci A; Gucuyener K
    J Child Neurol; 2005 Oct; 20(10):848-51. PubMed ID: 16417885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-associated weight gain in older children and teens with epilepsy.
    Wirrell EC
    Pediatr Neurol; 2003 Feb; 28(2):126-9. PubMed ID: 12699863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scope and use of valproate in epilepsy.
    Penry JK; Dean JC
    J Clin Psychiatry; 1989 Mar; 50 Suppl():17-22. PubMed ID: 2494154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.